New Zealand vs Syrian Arab Republic: Statin use vs average non hdl cholesterol levels
New Zealand
3.4
in 2018
Syrian Arab Republic
3.4
in 2018
New Zealand rank
74th
Syrian Arab Republic rank
74th
Statin use vs average non hdl cholesterol levels over time
- New Zealand
- Syrian Arab Republic
How they compare
New Zealand currently reports 3.4 against 3.4 in Syrian Arab Republic, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was New Zealand ahead.
New Zealand ranks 74th and Syrian Arab Republic ranks 74th of 189 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | New Zealand | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.48 | 3.44 | 1.04 | New Zealand |
| 1990s | 4.31 | 3.61 | 0.7 | New Zealand |
| 2000s | 3.92 | 3.63 | 0.29 | New Zealand |
| 2010s | 3.53 | 3.48 | 0.0556 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, New Zealand or Syrian Arab Republic?
- New Zealand, at 3.4 against 3.4 in Syrian Arab Republic as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between New Zealand and Syrian Arab Republic?
- 0, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Syrian Arab Republic?
- 39 years are reported by both, from 1980 to 2018.
- How do New Zealand and Syrian Arab Republic rank globally for statin use vs average non hdl cholesterol levels?
- New Zealand ranks 74th and Syrian Arab Republic ranks 74th of 189 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.